GlassScriptPhysician profile
Bridget A Bagert
NPI 1174589824
$198,197.26
in general payments reported to CMS, 2019-2025
13 companies · $99K in 2025
The $99K reported for 2025 was more than what 98% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $88.41 · 2022: $137 · 2023: $1,954 · 2024: $97K · 2025: $99K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $118K · Consulting Fee: $58K · Travel and Lodging: $18K · Food and Beverage: $3,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $118,203.00 |
| Consulting Fee | $58,066.50 |
| Travel and Lodging | $18,165.73 |
| Food and Beverage | $3,398.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $75,321.16 | 2019-2025 | Mavenclad, Mavenclad |
| Genzyme Corporation | $52,823.22 | 2022-2025 | |
| Tg Therapeutics, INC. | $50,370.89 | 2023-2025 | Briumvi |
| Amgen INC. | $8,778.12 | 2024-2025 | Uplizna |
| Genentech USA, INC. | $6,225.87 | 2024-2025 | Ocrevus |
| E.R. Squibb & Sons, L.L.C. | $4,429.76 | 2020-2024 | |
| Biogen, INC. | $119.44 | 2019-2024 | Vumerity, Tysabri |
| Boston Scientific Corporation | $111.51 | 2019 | |
| Abbvie INC. | $17.29 | 2024 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Bagert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.